Comparing Teleretinal Screening-Identified Diabetic Retinopathy With Diabetic Nephropathy and Other Markers of Systemic Disease.

Q3 Medicine International Ophthalmology Clinics Pub Date : 2025-01-01 Epub Date: 2024-12-23 DOI:10.1097/IIO.0000000000000544
Sean M Rodriguez, Eric B Hamill, Amritha Sundaresan, Danielle Guffey, Christina Y Weng
{"title":"Comparing Teleretinal Screening-Identified Diabetic Retinopathy With Diabetic Nephropathy and Other Markers of Systemic Disease.","authors":"Sean M Rodriguez, Eric B Hamill, Amritha Sundaresan, Danielle Guffey, Christina Y Weng","doi":"10.1097/IIO.0000000000000544","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Diabetic retinopathy and diabetic nephropathy are two major life-altering complications of diabetes mellitus. Identifying permissive and protective factors for diabetic retinopathy and nephropathy is imperative so that diabetic quality of life can be optimized and downstream complications can be minimized.</p><p><strong>Methods: </strong>We performed a large retrospective chart review of 997 patients at a county medical center with a majority Hispanic population. Through multivariable regression analysis, we identified significant factors associated with the presence of diabetic retinopathy or diabetic nephropathy. We also identified patients with a discordance between diabetic control and the severity of diabetic retinopathy and nephropathy.</p><p><strong>Results: </strong>Chronic kidney disease, baseline HbA1c, and systolic blood pressure were found to be positive risk factors for both diabetic retinopathy and diabetic nephropathy. Beta-blocker use and insulin use were identified as positive risk factors for diabetic retinopathy but not diabetic nephropathy. A higher body metabolic index (BMI) was found to be protective for diabetic retinopathy. We identified 7 patients with poor diabetic control (HbA1c >10%) but no diabetic retinopathy. There were no outlier patients found in the low glycemic exposure group.</p><p><strong>Conclusions and importance: </strong>Our results are similar to other large-cohort reviews identifying factors associated with diabetic retinopathy and nephropathy. We identified a small cohort with discordance between diabetic control and the development of diabetic retinopathy or nephropathy. Future studies should be conducted looking into reasons for the anomalous progression of disease in certain patients.</p>","PeriodicalId":14338,"journal":{"name":"International Ophthalmology Clinics","volume":"65 1","pages":"27-33"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Ophthalmology Clinics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/IIO.0000000000000544","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/23 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Diabetic retinopathy and diabetic nephropathy are two major life-altering complications of diabetes mellitus. Identifying permissive and protective factors for diabetic retinopathy and nephropathy is imperative so that diabetic quality of life can be optimized and downstream complications can be minimized.

Methods: We performed a large retrospective chart review of 997 patients at a county medical center with a majority Hispanic population. Through multivariable regression analysis, we identified significant factors associated with the presence of diabetic retinopathy or diabetic nephropathy. We also identified patients with a discordance between diabetic control and the severity of diabetic retinopathy and nephropathy.

Results: Chronic kidney disease, baseline HbA1c, and systolic blood pressure were found to be positive risk factors for both diabetic retinopathy and diabetic nephropathy. Beta-blocker use and insulin use were identified as positive risk factors for diabetic retinopathy but not diabetic nephropathy. A higher body metabolic index (BMI) was found to be protective for diabetic retinopathy. We identified 7 patients with poor diabetic control (HbA1c >10%) but no diabetic retinopathy. There were no outlier patients found in the low glycemic exposure group.

Conclusions and importance: Our results are similar to other large-cohort reviews identifying factors associated with diabetic retinopathy and nephropathy. We identified a small cohort with discordance between diabetic control and the development of diabetic retinopathy or nephropathy. Future studies should be conducted looking into reasons for the anomalous progression of disease in certain patients.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
远网膜筛查发现的糖尿病视网膜病变与糖尿病肾病及其他全身性疾病标志物的比较。
目的:糖尿病视网膜病变和糖尿病肾病是糖尿病的两大并发症。确定糖尿病视网膜病变和肾病的允许和保护因素是必要的,这样可以优化糖尿病患者的生活质量,并将下游并发症降到最低。方法:我们对一个以西班牙裔人口为主的县医疗中心的997名患者进行了大型回顾性图表回顾。通过多变量回归分析,我们确定了与糖尿病视网膜病变或糖尿病肾病存在相关的重要因素。我们还发现了糖尿病控制与糖尿病视网膜病变和肾病严重程度不一致的患者。结果:慢性肾脏疾病、基线HbA1c和收缩压被发现是糖尿病视网膜病变和糖尿病肾病的阳性危险因素。β受体阻滞剂和胰岛素的使用被确定为糖尿病视网膜病变的阳性危险因素,但不是糖尿病肾病。较高的身体代谢指数(BMI)对糖尿病视网膜病变有保护作用。我们确定了7例糖尿病控制不良(HbA1c≤10%)但无糖尿病视网膜病变的患者。低血糖暴露组无异常患者。结论和重要性:我们的结果与其他确定糖尿病视网膜病变和肾病相关因素的大队列综述相似。我们确定了一个小队列,在糖尿病控制和糖尿病视网膜病变或肾病的发展之间存在不一致。未来的研究应着眼于某些患者疾病异常进展的原因。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
International Ophthalmology Clinics
International Ophthalmology Clinics Medicine-Ophthalmology
CiteScore
1.40
自引率
0.00%
发文量
94
期刊介绍: International Ophthalmology Clinics is a valuable resource for any medical professional seeking to stay informed and up-to-date regarding developments in this dynamic specialty. Each issue of this quarterly publication presents a comprehensive review of a single topic in a new or changing area of ophthalmology. The timely, tightly focused review articles found in this publication give ophthalmologists the opportunity to benefit from the knowledge of leading experts in this rapidly changing field.
期刊最新文献
Retinal Microstructural and Microvascular Changes in Alzheimer Disease: A Review. Comparing Teleretinal Screening-Identified Diabetic Retinopathy With Diabetic Nephropathy and Other Markers of Systemic Disease. Demographics of Ophthalmology and Optometry Practices and Changes in Utilization Patterns of Procedures and Services Following Private Equity Acquisition. Follow-up Adherence After Teleretinal Screening for Diabetic Retinopathy. Glucagon-like Peptide-1 Receptor Agonists in the Management of Diabetic Retinopathy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1